logo
Unicommerce Esolutions logs 71% YoY rise in Q4 operating revenue

Unicommerce Esolutions logs 71% YoY rise in Q4 operating revenue

Time of India05-05-2025

Ecommerce software
firm
Unicommerce Esolutions
on Monday reported a 71% year-on-year (YoY) increase in its
operating revenue
at Rs 45 crore for the quarter ended March 2025.
#Pahalgam Terrorist Attack
Pakistan's economy has much more to lose than India's due to the ongoing tensions, warns Moody's Ratings
The day Pakistan got the power to poke India
India demands ADB to stop funds to Pakistan as fallout of Pahalgam terror attack deepens
The Gurugram-based firm's
net profit
for the quarter rose 17.8% to Rs 3.3 crore compared to Rs 2.8 crore in the same period last year. Sequentially, its profit fell by half from Rs 6 crore in Q3 FY25, due to a rise in expenses.
The company's total expenses rose to Rs 41 crore in Q4 from Rs 24 crore in the same period last year. A significant amount of the expenditure was attributed to employee benefits, which amounted to Rs 16 crore and other expenses at Rs 20 crore.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
If You Eat Ginger Everyday for 1 Month This is What Happens
Tips and Tricks
Undo
Its total income for the quarter stood at Rs 46 crore.
Founded in 2012, Unicommerce offers technology solutions to manage various operations, such as warehouse and inventory management, order management, omnichannel retail management, and seller management for ecommerce platforms.
Live Events
The company currently offers three product platforms: Convertway, a marketing automation platform; Uniware, an order processing platform; and Shipway, a logistics management platform.
Discover the stories of your interest
Blockchain
5 Stories
Cyber-safety
7 Stories
Fintech
9 Stories
E-comm
9 Stories
ML
8 Stories
Edtech
6 Stories
On March 21, the company completed the acquisition of the remaining 57.24% stake in shipping automation firm Shipway Technology, making it a wholly owned subsidiary. It had previously acquired a 42.76% stake in Shipway in December 2024 for Rs 68.4 crore.
With this, Unicommerce's overall revenue for FY25 grew by 31% to Rs 135 crore from Rs 103 crore in FY24. Its net profit grew by 38% to Rs 18 crore.
In February, Unicommerce CEO Kapil Makhija highlighted that the key growth drivers for the company would be the expansion of ecommerce through
digital adoption
, an increase in the total addressable market through complementary offerings, client acquisition, and an extended product portfolio.
The company's clients include new-age consumer brands like omnichannel eyewear retailer
Lenskart
, homegrown wearable and audio product brand Boat, skincare brand
Mamaearth
and online fashion retailer Myntra.
It closed on Monday up 6.27% at Rs 127.15 on the BSE. The results were declared post-market hours.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US stock market today: S&P 500 flat, Dow Jones down, Nasdaq‑100 up— biggest gainers, losers as Wall Street eyes US-China trade talks and potential tariff deal
US stock market today: S&P 500 flat, Dow Jones down, Nasdaq‑100 up— biggest gainers, losers as Wall Street eyes US-China trade talks and potential tariff deal

Time of India

time36 minutes ago

  • Time of India

US stock market today: S&P 500 flat, Dow Jones down, Nasdaq‑100 up— biggest gainers, losers as Wall Street eyes US-China trade talks and potential tariff deal

US stock market live update: Dow Jones drops 185 points as investors await US-China trade talks progress- The US stock market opened slightly weaker on Monday, June 9, as Wall Street turned its attention to critical trade talks between the United States and China. Early trading saw the Dow Jones Industrial Average fall by 185 points, or about 0.5%, marking a cautious start to the week. The S&P 500 dipped 0.1%, while the Nasdaq Composite edged up slightly by 0.1% around 9:35 a.m. Eastern Time. Traders are closely watching the developments in London, where senior officials from both countries are meeting to ease long-standing trade tensions. The discussions aim to address a range of economic disputes and possibly roll back mutual tariffs that have been weighing on global supply chains for years. How are the major indices performing? S&P 500 (SPY): Sitting steady at about 599.15, virtually unchanged from the previous close, remaining just under the 6,000 mark. Dow Jones Industrial Average (DIA): Dropping roughly 0.21% to 427.47, reflecting some investor caution. Nasdaq-100 (QQQ): Climbing around 0.16% to 530.77, fueled by strength in the tech sector. Which stocks are making the biggest moves? Top gainers today include: by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Here's What a New Roof Should Cost in 2025 Learn More Undo Warner Bros Discovery: Surging 7-9% following news of a company split. IonQ: Up about 3% after announcing an acquisition of Oxford Ionics. Merck: Rising 1.1%, boosted by positive trial results. Nvidia: Gaining between 1.3% and 2.3%, riding the wave of AI enthusiasm. Qualcomm: Jumping 4.4% on completion of its Alphawave IP purchase. Apple: Adding 0.7%, supported by new AI features unveiled at the WWDC event. Biggest losers include: Robinhood: Dropping 7.4% after being excluded from the S&P 500 index. Tesla: Down between 0.3% and 2%, impacted by a recent downgrade and fallout from Musk-related news. EchoStar: Falling 8.2% amid bankruptcy rumors. Live Events Why are the US and China meeting now — and what's at stake for the stock market? This week's US-China trade talks are seen as pivotal for the global economy. Tariffs imposed in past years have disrupted everything from electronics to heavy equipment. Though those tariffs are currently paused, no permanent deal has been reached. Analysts believe that progress in these talks could help avoid a potential economic slowdown or even a recession, especially if they result in the reduction or removal of tariffs on both sides. A positive outcome could also reignite investor confidence and fuel another leg up in the US stock market rally. These modest moves reflect investor hesitancy. Market players are clearly waiting for concrete news before making big decisions. The S&P 500 remains just 2.5% below its all-time high, buoyed by hopes that the US may reach trade agreements that roll back tariffs globally. What's driving the stock market recovery in 2025? One major factor behind the stock market's strong recovery has been the belief that President Donald Trump will reduce trade barriers as part of broader global deals. After plunging by nearly 20% from its peak two months ago, the S&P 500 has made a swift comeback. That optimism is largely driven by expectations that smoother trade relations — particularly with major economies like China — will relieve pressure on multinational companies and bring stability back to supply chains. Are tariffs still in effect, and why does it matter now? Currently, both the US and China have put a pause on new tariffs, but existing ones remain. These tariffs have cost industries billions, increased consumer prices, and created uncertainty for global manufacturers. What's important now is whether these paused tariffs are finally lifted. This could significantly improve the flow of goods, lower costs, and potentially lead to more business investments, especially in sectors like tech, agriculture, and manufacturing. Could US-China trade deals shape the next market trend? Absolutely. Any meaningful breakthrough in US-China trade negotiations could serve as a key catalyst for markets. Investors are looking for long-term clarity, not just temporary relief. If Monday's talks in London show signs of real progress, we could see increased investor confidence, reduced market volatility, and fresh momentum across Dow Jones, S&P 500, and Nasdaq. But without a deal, continued uncertainty could weigh on the markets in the coming weeks. What's driving the market today? Trade talks between the U.S. and China in London continue to shape investor sentiment, contributing to the Dow's decline and a slight Nasdaq boost. Inflation concerns remain front and center , with traders awaiting this week's CPI and core PCE data releases. Expectations suggest the Federal Reserve may hold interest rates steady for now. Sector trends show technology stocks powering the gains, while healthcare lags behind. What should investors watch next? Investors should keep a close eye on the statements or outcomes from the US-China meetings. Any mention of progress on tariff rollbacks, trade agreements, or economic cooperation could trigger immediate market reactions. It's also worth noting that the Federal Reserve's next move, broader economic indicators, and the 2024 US election climate remain in focus as secondary factors influencing the market direction. FAQs: Q1: Why did the Dow Jones fall 185 points today? The Dow Jones dropped due to investor caution ahead of the US-China trade talks. Q2: What are US-China trade talks about? The talks aim to ease tariffs and settle long-running trade disputes affecting the global economy.

Blake Lively faces more legal trouble as her beauty brand strikes back with lawsuit - here's what the problem is
Blake Lively faces more legal trouble as her beauty brand strikes back with lawsuit - here's what the problem is

Time of India

time36 minutes ago

  • Time of India

Blake Lively faces more legal trouble as her beauty brand strikes back with lawsuit - here's what the problem is

Blake Lively apparently is at the heart of multiple controversies lately. Blake Lively's beauty business is going through a lot of trouble. Family Hive LLC , her company, just filed a trademark lawsuit and is also dealing with the fallout from a well-known harassment case. Lively is having a rough time both personally and professionally. Her business is trying to protect its name, but sales are falling and she is still in legal trouble with co-star Justin Baldoni . Why is Blake Lively's brand suing another company? Blake Brown , Blake Lively's growing hair care company, is in a trademark fight with a company based in Utah. According to recent court filings, Utah-based businesswoman Kimberlie Hamner, the owner of the Beauty by Blake trademark, is being sued by Lively's company, Family Hive LLC. The haircare brand Blake Lively is fighting to stop the competition's "Beauty By Blake" trademark. According to the lawsuit, consumers may become confused by Hamner's trademark because it is too similar to Blake Lively's brand name, as quoted in a report by the Blast. Live Events The Blake Brown product line was formally introduced at Target this summer, but the trademarks were all submitted in 2023 and are still pending approval. Notably, following Blake Lively's filings, Hamner submitted her Beauty by Blake trademark application in September 2024 with the intention of marketing "cosmetic oils" and "serums for cosmetic purposes." What did the court documents reveal? Leo M. Loughlin, the lawyer for Family Hive, stated in the document that was obtained by the Daily Mail that the competing trademark presents a likelihood of confusion and has the potential to damage the Blake Brown brand. He added that Hamner has "no connection whatsoever" to Family Hive and that his products could give consumers the false impression that the company is associated with or supports them. ALSO READ: As Musk exits, DOGE employees are being booted from offices; many fired staff now being rehired How has the lawsuit with Justin Baldoni affected her business? Following her sexual harassment lawsuit against Justin Baldoni in December 2024, Blake Lively's hair-care brand saw a sharp decline in sales, reportedly falling by as much as 78%. This latest lawsuit comes at a challenging time for her business endeavors. The brand was once thought to be worth $100 million, but it is now predicted that Blake Brown will make less than $15 million in total sales in 2025. Lively's brand is still growing in the beauty industry, but the actress is currently balancing her business endeavors with courtroom drama. It's obvious that Blake Brown's future could be as complicated as a bad hair day, especially with trademark tensions escalating. FAQs What is Blake Lively's beauty brand suing for? Her company claims that another brand's name, Beauty by Blake, is too similar and could confuse customers. Is Blake's business struggling? Yes, sales have decreased significantly, particularly since her lawsuit against actor Justin Baldoni made headlines. Economic Times WhatsApp channel )

Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal
Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

Time of India

time38 minutes ago

  • Time of India

Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

Cosmetics maker L'Oreal agreed to acquire a majority stake in British skincare brand Medik8, in a strategic move to strengthen its presence in the booming skincare market. The French beauty giant announced the deal on Monday, though financial terms were not disclosed. The transaction, which sees UK-based private equity firm Inflexion selling its majority holding, reportedly values Medik8 at around 1 billion Euro, according to a source familiar with the matter. Inflexion will retain a minority share, while L'Oreal has secured the option to eventually buy out all remaining shareholders, Reuters reported. 'We are delighted to welcome Medik8 to the L'Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio,' Cyril Chaupuy, president of L'oreal Luxe said. 'This acquisition further strengthens L'Oreal's luxe portfolio, adding a premium science-backed skincare brand with a proven track record of success, with strong potential for global growth,' the company said in a statement. L'Oreal will begin consolidating Medik8's sales once the transaction officially closes. The acquisition is expected to be finalised in the coming months, pending regulatory approvals and standard closing conditions. Simon Coble, CEO of Medik8 also expressed excitement on the brand's behalf. 'I am delighted to be joining forces with a company which shares our vision for the brand's future growth and whose core values align with our deep commitment to science, innovation and above all, results without compromise. I look forward to the next stage in Medik8's journey, as we work together to bring our innovative products to a wider audience.' Founded in the UK, Medik8 has built a loyal customer base with its vitamin A-focused anti-ageing creams and serums. The brand is seen as a natural fit for L'Oreal's luxury division, which includes skincare and fragrance names such as Lancome, Aesop, and Miu Miu. Last year, sales in L'Oreal's luxe segment grew by just 2.7%, its weakest performance across divisions, as inflation pushed consumers toward more affordable alternatives. However, the unit scrored better than rival LVMH's beauty arm. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store